Take a closer look at bone histology of TYMLOS
As a safety measure, a subset of patients in the TYMLOS (n=36) and placebo (n=35) groups underwent bone biopsies after 12 to 18 months of treatment1
In both groups, qualitative and quantitative* histology showed normal bone microarchitecture and no evidence of woven bone, marrow fibrosis, or mineralization defects1
Fifty-five biopsies were adequate for quantitative histomorphometry assessment in the TYMLOS (n=27) and placebo (n=28) groups.1
View the clinical results of the 18-month pivotal study
Reference: 1.TYMLOS® [prescribing information]. Waltham, MA: Radius Health, Inc; 2018.